Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CJ-15314 by HK inno.N for Psoriasis: Likelihood of Approval
CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Psoriasis. According to GlobalData, Phase I...
CJ-15314 by HK inno.N for Rheumatoid Arthritis: Likelihood of Approval
CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase...
CJ-15314 by HK inno.N for Psoriasis: Likelihood of Approval
CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Psoriasis. According to GlobalData, Phase I...
CJ-15314 by HK inno.N for Rheumatoid Arthritis: Likelihood of Approval
CJ-15314 is under clinical development by HK inno.N and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase...